Fred Alger Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,373	Closed	-$860K	–	439
2025 Q1	$860K	Buy	+7,373	New	+$840K	﹤0.01%	335
2024 Q4	–	Sell	-9,466	Closed	-$851K	–	417
2024 Q3	$851K	Buy	+9,466	New	+$826K	﹤0.01%	354
2023 Q3	–	Sell	-17,422	Closed	-$1.25M	–	470
2023 Q2	$1.25M	Buy	+17,422	New	+$1.29M	0.01%	368
2021 Q1	–	Sell	-14,670	Closed	-$1.2M	–	483
2020 Q4	$1.2M	Sell	14,670 -331	-2%	-$24.8K	﹤0.01%	357
2020 Q3	$1.07M	Sell	15,001 -7,999	-35%	-$623K	﹤0.01%	339
2020 Q2	$1.89M	Buy	23,000 +4,000	+21%	+$308K	0.01%	306
2020 Q1	$1.12M	Buy	19,000 +3,000	+19%	+$244K	﹤0.01%	309
2019 Q4	$1.65M	Buy	16,000 +1,000	+7%	+$40.4K	0.01%	304
2019 Q3	$304K	Sell	15,000 -5,000	-25%	-$128K	﹤0.01%	390
2019 Q2	$515K	Buy	+20,000	New	+$401K	﹤0.01%	379